In November Australian Psychiatry Review features a focus section on psychiatric genetics, rejuvenated by recent replications of genome-wide association studies. Other highlights of the literature reviewed this month include Atigari and Healy’s suggestion that the proconvulsant effects of clozapine. lithium, and ketamine, may be a novel therapeutic principle rather than a side-effect. Jelovac and colleagues provide a systematic review showing maintenance ECT does not change relapse after a primary ECT course. Zipursky and colleagues persuasively argue against what they describe as the myth that schizophrenia is a neurodegenerative disorder. Finally, Priebe and colleagues report that small financial incentives can greatly increase treatment adherence in previously poorly adherent patients on depot antipsychotics.